In vivo CRISPR screening reveals targets to reprogram long-lived effected T cells for cancer immunotherapy-武汉大学医学研究院

Wuhan University

WHO WE ARE

Overview Leadership
FACULTY

Intramural faculty Extramural faculty
RESEARCH

Infection and Immunity Metabolic Diseases Cancer Biology Brain and Neurobiology Cell and Developmental Biology RNA Biology and Functional Genomics Gene Editing and Drug Development
Events & Symposia

Symposia Events Journal

WHO WE ARE

Overview

Leadership
FACULTY

Intramural faculty

Extramural faculty
RESEARCH

Infection and Immunity

Metabolic Diseases

Cancer Biology

Brain and Neurobiology

Cell and Developmental Biology

RNA Biology and Functional Genomics

Gene Editing and Drug Development
Events & Symposia

Symposia

Events

Journal

Wuhan University

Events & Symposia

In vivo CRISPR screening reveals targets to reprogram long-lived effected T cells for cancer immunotherapy

POSTTIME：Jan. 07, 2020 NUM：

Pre：Targeting Kinases via Protein Degradation

Next：Histone H3K36 methylation in genome regulation and tumor suppression

Tel: 0086-27-68750205　 Email: mri@whu.edu.cn

Contact address: Donghu Road, No. 115, Wuchang District, Wuhan, Hubei Province, P.R. China. 430071

Copyright @ 2016~2024 Medical Research Institute